Search

Search Bar
01/07/2021 Pacemaker Lead Entrapment Complicating Heterotopic Transcatheter Tricuspid Valve Implantation
Asmarats, L, Li, CH, Millan, X, Moustafa, AH, Serra, A, Arzamendi, D. Pacemaker Lead Entrapment Complicating Heterotopic Transcatheter Tricuspid Valve Implantation. CANADIAN JOURNAL OF CARDIOLOGY. 2021; 37(7)DOI:10.1016/j.cjca.2021.04.009. PMID:33933608. IF:6.617(Q2/3D).
01/07/2021 EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)
Burri, H, Starck, C, Auricchio, A, Biffi, M, Burri, M, D'Avila, A, Deharo, JC, Glikson, M, Israel, C, Lau, CP, Leclercq, C, Love, CJ, Nielsen, JC, Vernooy, K, Dagres, N, Boveda, S, Butter, C, Marijon, E, Braunschweig, F, Mairesse, GH, Gleva, M, Defaye, P, Zanon, F, Lopez-Cabanillas, N, Guerra, JM, Vassilikos, VP, Oliveira, MM. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). EUROPACE. 2021; 23(7)DOI:10.1093/europace/euaa367. PMID:33878762. IF:5.486(Q2/4D).
01/07/2021 Incidence, predictors, and clinical impact of bleeding recurrence in patients with prior gastrointestinal bleeding undergoing LAAC
Faroux, L, Cruz-Gonzalez, I, Arzamendi, D, Freixa, X, Nombela-Franco, L, Peral, V, Caneiro-Queija, B, Mangieri, A, Trejo-Velasco, B, Asmarats, L, Regueiro, A, McInerney, A, Gonzalez, AM, Estevez-Loureiro, R, Laricchia, A, O'Hara, G, Rodes-Cabau, J. Incidence, predictors, and clinical impact of bleeding recurrence in patients with prior gastrointestinal bleeding undergoing LAAC. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 2021; 44(7)DOI:10.1111/pace.14293. PMID:34110038. IF:1.912(Q4/8D).
01/09/2022 Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau europeen de traitement d'arrhythmies cardiaques)-group
Muller-Edenborn, B, Moreno-Weidmann, Z, Venier, S, Defaye, P, Park, CI, Guerra, J, Alonso-Martin, C, Bazan, V, Vinolas, X, Rodriguez-Font, E, Garcia, BC, Boveda, S, Combes, S, Albenque, JP, Guy-Moyat, B, Trenk, D, Eichenlaub, M, Chen, J, Lehrmann, H, Neumann, FJ, Arentz, T, Jadidi, A. Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau europeen de traitement d'arrhythmies cardiaques)-group. Clinical Research in Cardiology. 2022; 111(9)DOI:10.1007/s00392-021-01973-1. PMID:34854991. IF:5.000(Q2/4D).